SPONSORSHIP & SUPPORT
This educational activity is jointly provided by Global Education Group and Spire Learning.
This activity is supported by educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals.
Chronic spontaneous urticaria (CSU) is a chronic immune-mediated condition characterized by sudden development of wheals and/or angioedema, as well as presenting with significant debilitation and considerable burden on patients’ quality of life. The diagnosis and management of CSU is complex, and despite currently available treatment options, many patients with CSU remain inadequately controlled. As a result, many health care professionals may miss opportunities to deliver evidence-based care utilizing safe and effective, targeted therapies. Join our expert faculty as they discuss patient scenarios to highlight methods to avoid missed opportunities for the care team, develop curative (as opposed to prophylactic symptom control) strategies, and ultimately provide optimal care for patients with CSU.
The target audience will be comprised of allergists, dermatologists, specialty nurse practitioners, specialty physician assistants, and managed care/pharmacy directors.
Upon completion of this educational activity, learners should be better able to:
ACCREDITATION AND CREDIT DESIGNATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Spire Learning. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Spire Learning, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 0.25 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation Statement
Global Education Group designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-21-153-H01-P) This is a knowledge-based activity.
HOW TO RECEIVE CREDIT
There is no fee for this educational activity. To receive credit for your participation in this educational activity:
- Read the objectives and other introductory CME information
- Complete the preassessment prior to the start of the activity
- Participate in the chronic urticaria case activity
- Complete the postassessment and evaluation at the conclusion of the activity
If you are seeking credit, you must complete the evaluation at the conclusion of the activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
CONFLICTS OF INTEREST STATEMENT
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Chesahna Kindred, MD, MBA, FAAD (Chair)
Assistant Professor of Dermatology
Howard University College of Medicine
Kindred Hair & Skin Center
Consulting Fees (eg, Advisory Board): Aerolase; Eli Lilly and Company; Sun Pharmaceuticals; UCB, Inc
Speakers’ Bureau: Aerolase; Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Nutrafol; Sun Pharmaceuticals; UCB, Inc
Jonathan A. Bernstein, MD
Professor of Clinical Medicine
University of Cincinnati Medical Center
Partner, Bernstein Allergy Group and Clinical Research Center
Consulting Fees (eg, Advisory Board): Allakos Inc; AstraZeneca; BioCryst Pharmaceuticals, Inc; BioMarin Pharmaceutical Inc; Blueprint Medicines; Celldex Therapeutics; CSL Behring; Genentech, Inc; Ionis Pharmaceuticals, Inc; Merck & Co, Inc; Novartis Pharmaceuticals Corporation; Pharming; Pharvaris; Sanofi Regeneron; Takeda Shire
Contracted Research: Allakos Inc; AstraZeneca; BioCryst Pharmaceuticals, Inc; BioMarin Pharmaceutical Inc; Blueprint Medicines; Celldex Therapeutics; CSL Behring; Genentech, Inc; Ionis Pharmaceuticals, Inc; Merck & Co, Inc; Novartis Pharmaceuticals Corporation; Pharming; Pharvaris; Sanofi Regeneron; Takeda Shire
Honoraria: AstraZeneca; BioCryst Pharmaceuticals, Inc; CSL Behring; Genentech, Inc; Merck & Co, Inc; Novartis Pharmaceuticals Corporation; Pharming; Sanofi Regeneron; Takeda Shire
Speakers’ Bureau: AstraZeneca; BioCryst Pharmaceuticals, Inc; CSL Behring; Genentech Inc; Merck & Co, Inc; Novartis Pharmaceuticals Corporation; Pharming; Sanofi Regeneron; Takeda Shire
EDUCATIONAL PLANNING COMMITTEE
Global Education Group
Rhys Williams, MSN, FNP-C, RN; Lindsay Borvansky; Andrea Funk; Liddy Knight; Ashley Cann; Kim Rodriguez: No relevant financial relationships with any commercial interests.
Mairead Early, Christopher Washburn, PhD, and Kimberly Miniter have nothing to disclose.
Lindsay Borvansky: No relevant financial relationships with any commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Spire Learning do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Spire Learning, LLC, is committed to protecting the privacy of personal information from our participants and educational collaborators. Spire maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.
Collection and Use of Your Personal Information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected and retained, and used by Spire Learning, LLC, to continuously improve the learning experience.
Spire Learning, LLC, will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Spire will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.
Copyright © 2022 by Spire Learning, LLC and Global Education Group. All rights reserved including translation into other languages. No part of this publication or activity may be reproduced or transmitted in any form, by any means, without prior written permission of Spire Learning, LLC.